EMEA-002440-PIP01-18

Key facts

Active substance
Baloxavir marboxil
Therapeutic area
Infectious diseases
Decision number
P/0300/2019
PIP number
EMEA-002440-PIP01-18
Pharmaceutical form(s)
  • Film-coated tablet
  • Granules for oral suspension
Condition(s) / indication(s)
  • Prevention of influenza infection
  • Treatment of influenza
Route(s) of administration
Oral use
Contact for public enquiries
Roche Registration GmbH

Tel. +41 6168 79411
E-mail: global.paediatrics@roche.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating